Related Experiment Video

Updated: Apr 16, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Saul Genuth, MD: clinical researcher and leader in developing modern diabetes treatment

Alan M Jacobson¹, David M Nathan²

¹Research Institute, Winthrop University Hospital and Stony Brook School of Medicine, Mineola, NY amjacobson@winthrop.org.

|February 26, 2015

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study.

medRxiv : the preprint server for health sciences·2026

Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood Counts.

Diabetes technology & therapeutics·2025

Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study.

Diabetologia·2025

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience.

Diabetes care·2025

Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.

The lancet. Diabetes & endocrinology·2025

The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Diabetes care·2025

See all related articles